Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
35
Number of overlapping holdings
26.9%
% of XBI's 131 holdings also in WDNA
39.3%
% of WDNA's 91 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 1.2% | 1.9% | 1.2% |
|
SAREPTA THERAPEUTICS INC | 1.1% | 1.1% | 1.1% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.1% | 1.6% | 1.1% |
|
BLUEPRINT MEDICINES CORP. | 1.1% | 2.2% | 1.1% |
|
AMGEN INC | 1.1% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to WDNA
|
CRINETICS PHARMACEUTICALS INC | 1.2% |
|
CYTOKINETICS INC | 1.2% |
 |
ROIVANT SCIENCES LTD. | 1.2% |
|
VIKING THERAPEUTICS, INC. | 1.1% |
|
KRYSTAL BIOTECH, INC. | 1.1% |
|
EXELIXIS INC | 1.1% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | 1.1% |
|
ARCUTIS BIOTHERAPEUTICS INC | 1.1% |
|
NEUROCRINE BIOSCIENCES INC | 1.1% |
|
INSMED INC | 1.1% |
XBI Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.0% |
|
FATE THERAPEUTICS INC | -2.5% |
|
TWIST BIOSCIENCE CORP. | -2.4% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
ELI LILLY & CO | -1.9% |
|
CARIBOU BIOSCIENCES, INC. | -1.4% |
|
CATALENT INC | -1.3% |
|
DANAHER CORP | -1.3% |
|
REPLIGEN CORP | -1.2% |
 |
NOVARTIS AG | -1.2% |